Abatacept
dc.contributor.advisor | Denburg, Michelle |
dc.contributor.advisor | Razzaghi, Hanieh |
dc.contributor.advisor | Bailey, Charles |
dc.contributor.author | Goodwin Davies, Amy |
dc.contributor.other | Children's Hospital of Philadelphia |
dc.date.accessioned | 2024-06-10T19:03:30Z |
dc.date.available | 2024-06-10T19:03:30Z |
dc.date.created | 2020-03-04 |
dc.description | This concept set contains codes pertaining to the medication abatacept. It was developed by authors of Denburg et. al., 2019 (DOI: 10.1681/ASN.2019040365), including Michelle Denburg (clinician), Hanieh Razzaghi (data scientist/informaticist) and Charles Bailey (clinician/informaticist). Please note: As this concept set was developed five years ago, it should be reviewed and updated prior to reuse in any further studies. Furthermore it is not at the Semantic Clinical Drug Form/Semantic Clinical Drug Group level so does not adhere to current best practices within PEDSnet. |
dc.description.abstract | This concept set was intended to identify Abatacept exposures among pediatric nephrology cohorts such as Glomerular Disease or Membranoproliferative Glomerulonephritis (MPGN). |
dc.identifier.uri | https://pedsnet.org/metadata/handle/20.500.14642/597 |
dc.provenance | This concept set was developed for the Membranoproliferative Glomerulonephritis (MPGN) in PEDSnet study. |
dc.publisher | PEDSnet |
dc.relation.isreferencedby | Denburg MR, Razzaghi H, Bailey C, Soranno DE, et al. December 2019. "Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research." *JASN* 30(12):p 2427-2435. DOI: [10.1681/ASN.2019040365](doi.urg/10.1681/ASN.2019040365) |
dc.relation.uri | https://atlassian.chop.edu/bitbucket/projects/COD/repos/glean_codesets/browse/drug/abatacept.csv |
dc.rights | a CC-BY Attribution 4.0 License. |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.subject | Concept Set Development::Content Data Model::PCORnet Data Model |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Brand Pack Name |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Form |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Form |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Ingredient |
dc.subject.mesh | Abatacept |
dc.subject.mesh | Selective T Cell Costimulation Modulator |
dc.subject.mesh | Immunologic Agent |
dc.subject.other | RxNorm |
dc.subject.other | RxNorm Extension |
dc.title | Abatacept |
dspace.entity.type | ConceptSet |
local.quality.status | Deprecated |
local.subject.flat | PCORnet Data Model |
local.subject.flat | Brand Pack Name |
local.subject.flat | Semantic Branded Drug |
local.subject.flat | Semantic Clinical Drug |
local.subject.flat | Semantic Branded Drug Form |
local.subject.flat | Semantic Clinical Drug Form |
local.subject.flat | Ingredient |
local.subject.flat | Clinician Reviewed |
relation.isConceptSetOfConceptSet | ac367836-e6ad-4a5c-a5c6-cb0b0116bd10 |
relation.isConceptSetOfConceptSet.latestForDiscovery | ac367836-e6ad-4a5c-a5c6-cb0b0116bd10 |
relation.isStudyOfConceptSet | b9ba1a84-3c64-47c4-a896-53957d51d720 |
relation.isStudyOfConceptSet.latestForDiscovery | b9ba1a84-3c64-47c4-a896-53957d51d720 |
Files
Original bundle
1 - 1 of 1